Patent · US Active

Aminopyrazole kinase inhibitors

US7851500B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 2008
Grant dateDec 14, 2010
Priority date—
Expiry dateJan 4, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.